Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 23, 2019updated 25 Jan 2019 5:50am

Pharmaseal launches new SaaS clinical trial management platform

UK-based clinical trial management solutions provider Pharmaseal has launched a new software-as-a-service (SaaS) platform intended to simplify the management of clinical trials.

Dubbed Engility CTMS, the new clinical trial management system (CTMS) is designed to boost the level of governance and control required by organisations to maintain effective monitoring of their trials.

The platform is said to feature automation, intuitive interface and flexible cloud architecture. It can be leveraged by any biopharmaceutical or medical device company.

Pharmaseal further noted that Engility CTMS can deliver new product updates within a managed validation framework.

The system can track study design and progress such as enrolment, milestones and required documents. It can also be used to maintain relevant institutions, investigators, IRB/IEC’s and study teams.

In addition, companies will be able to plan, track and support global site and investigator payments, as well as schedule and trigger payment requests.

Pharmaseal CEO and founder Daljit Cheema said: “We are extremely proud to finally launch our new company and release our innovative CTMS product. Our collective passion for continuous innovation led to developing the Engility platform and our first product, Engility CTMS.

Content from our partners
The importance of reference products in biosimilar trials, and how to source them
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

“With Engility, we can enable more companies to improve their governance and oversight processes. Pharmaseal has proven that by applying advanced engineering and automation, technology can streamline and consolidate complex trial management activities.”

The platform can be easily integrated into eClinical application portfolio, including EDC and eTMF, through REST API. Pharmaseal added that the system improves clinical trial transparency.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU